115 related articles for article (PubMed ID: 70413)
1. Terminal deoxynucleotidyl transferase activity and cell surface antigens of two unique cell lines (NALM-1 and BALM-2) of human leukemic origin.
Sahai Srivastava BI; Minowada J
Int J Cancer; 1977 Aug; 20(2):199-205. PubMed ID: 70413
[TBL] [Abstract][Full Text] [Related]
2. Absence of thymus-derived lymphocyte markers in myelogenous leukemia (Ph1+) cell line K-562.
Lozzio CB; Lozzio BB; Yang WK; Ichiki AT; Bamberger EG
Cancer Res; 1976 Dec; 36(12):4657-62. PubMed ID: 63324
[TBL] [Abstract][Full Text] [Related]
3. Deoxynucleotide-polymerizing enzyme activities in T- and B-cells of acute lymphoblastic leukemia origin.
Srivastava BI
Cancer Res; 1976 May; 36(5):1825-30. PubMed ID: 1083765
[TBL] [Abstract][Full Text] [Related]
4. Heterotransplantation and clonal growth of human Ph'-chromosome-positive leukemia-cell (NALM-1) and B-cell leukemia-cell (BALM-2) lines.
Kubonishi I; Freeman AI; Minowada J
Cancer; 1980 May; 45(9):2324-9. PubMed ID: 6929725
[TBL] [Abstract][Full Text] [Related]
5. A non-T, non-B human leukemia cell line (NALM-1): establishment of the cell line and presence of leukemia-associated antigens.
Minowada J; Tsubota T; Greaves MF; Walters TR
J Natl Cancer Inst; 1977 Jul; 59(1):83-7. PubMed ID: 301573
[TBL] [Abstract][Full Text] [Related]
6. Terminal deoxynucleotidyl transferase activity in human leukemic cells and in normal human thymocytes.
McCaffrey R; Harrison TA; Parkman R; Baltimore D
N Engl J Med; 1975 Apr; 292(15):775-80. PubMed ID: 1054106
[TBL] [Abstract][Full Text] [Related]
7. High terminal deoxynucleotidyl transferase activity in acute myelogenous leukemia.
Sahai Srivastava BI; Khan SA; Henderson ES
Cancer Res; 1976 Oct; 36(10):3847-50. PubMed ID: 1085195
[TBL] [Abstract][Full Text] [Related]
8. High terminal deoxynucleotidyl transferase activity in a new T-cell line (RPMI 8402) of acute lymphoblastic leukemia origin.
Srivastava BI; Minowada J; Moore GE
J Natl Cancer Inst; 1975 Jul; 55(1):11-14. PubMed ID: 808634
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the expression of terminal deoxynucleotidyl transferase and common acute lymphoblastic leukemia antigen in selected hematologic malignancies.
Bodner SM; Casavant CH; McHugh TM; Stites DP
Diagn Immunol; 1985; 3(3):139-44. PubMed ID: 2932276
[TBL] [Abstract][Full Text] [Related]
10. Two t(9;22) leukemia cell lines (NALM-24 and NALM-25) with bi-phenotypic characteristics and an EBV-positive B-cell non-leukemia cell line (B262) established from a patient with acute lymphoblastic leukemia.
Matsuo Y; Ariyasu T; Adachi T; Tsubota T; Minowada J
Hum Cell; 1991 Dec; 4(4):339-42. PubMed ID: 1667895
[TBL] [Abstract][Full Text] [Related]
11. Establishment of a Ph1-positive human cell line (BV173).
Pegoraro L; Matera L; Ritz J; Levis A; Palumbo A; Biagini G
J Natl Cancer Inst; 1983 Mar; 70(3):447-53. PubMed ID: 6572735
[TBL] [Abstract][Full Text] [Related]
12. Terminal deoxynucleotidyl transferase in the blastic phase of chronic myelogenous leukemia: an indicator of response to vincristine and prednisone therapy.
Tanaka M; Kaneda T; Hirota Y; Yoshida S; Kitajima K
Am J Hematol; 1980; 9(3):287-93. PubMed ID: 6940442
[TBL] [Abstract][Full Text] [Related]
13. Terminal transferase in acute lymphoblastic leukemia in gibbons.
Sarin PS; Virmani M; Friedman B
Biochim Biophys Acta; 1980 Jun; 608(1):62-71. PubMed ID: 6930304
[TBL] [Abstract][Full Text] [Related]
14. Cytogenetic study of a new Ph1-positive cell line (NALM-1).
Sonta SI; Minowada J; Tsubota T; Sandberg AA
J Natl Cancer Inst; 1977 Sep; 59(3):833-7. PubMed ID: 302341
[TBL] [Abstract][Full Text] [Related]
15. Demonstration of terminal deoxynucleotidyl transferase in single cells by indirect immunofluorescence. II. An examination of specificity.
Barr RD; Koekebakker M; Mahony J
Leuk Res; 1984; 8(3):429-34. PubMed ID: 6087036
[TBL] [Abstract][Full Text] [Related]
16. Enrichment of terminal deoxynucleotidyl transferase activity by cell separation.
Sarin PS; Virmani M; Gallo RC
Adv Exp Med Biol; 1982; 145():337-56. PubMed ID: 6981292
[TBL] [Abstract][Full Text] [Related]
17. Two new acute lymphoblastic leukemia cell lines with early B-cell phenotypes.
Findley HW; Cooper MD; Kim TH; Alvarado C; Ragab AH
Blood; 1982 Dec; 60(6):1305-9. PubMed ID: 6982733
[TBL] [Abstract][Full Text] [Related]
18. Novel B-cell acute lymphoblastic leukemia sister cell lines BALM 19-23 and BALM-26 with interclonal proliferative and phenotypic heterogeneity from a patient with hypercalcemia.
Matsuo Y; Drexler HG; Kojima K; Sugimoto A; Harashima A; Okochi A; Hara M; Orita K
Hum Cell; 2002 Sep; 15(3):160-70. PubMed ID: 12703546
[TBL] [Abstract][Full Text] [Related]
19. Cytogenetic and immunoglobulin markers of human leukemic B-cell lines.
Minowada J; Oshimura M; Tsubota T; Higby DJ; Sandberg AA
Cancer Res; 1977 Sep; 37(9):3096-9. PubMed ID: 406986
[TBL] [Abstract][Full Text] [Related]
20. Rabbit antiserum against a non-T, non-B leukemia cell line that carries the Ph1 chromosome (NALM-1): antibody specific to a non-T, non-B acute lymphoblastic leukemia antigen.
Koshiba H; Minowada J; Pressman D
J Natl Cancer Inst; 1978 Oct; 61(4):987-91. PubMed ID: 81309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
